AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35251561 — intervention group
Group type: EXPERIMENTAL
Intervention: EPOC training in addition to conventional medication
Number of subjects: 60
Study 35251561 — intervention group
Group type: COMPARATOR
Intervention: Conventional hypertension medication
Number of subjects: 60
Study 34034929 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS-directed therapy comprising four to 11 courses of i.v. methotrexate (5 g/m2) and 10 to 19 intrathecal chemotherapy injections, depending on risk group and CNS status.
Number of subjects: 1930
Study 34034929 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS-3 status
Number of subjects: 1930
Study 34034929 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS-directed therapy
Number of subjects: 1930
Study 32020813 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-bronchodilator spirometry
Number of subjects: 1015
Study 32020813 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-bronchodilator spirometry
Number of subjects: 1015
Study 32020813 — intervention group
Group type: EXPERIMENTAL
Intervention: GOLD criteria
Number of subjects: 1015
Study 32020813 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe disease
Number of subjects: 1015
Study 32020813 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment status
Number of subjects: 1015
Study 32020813 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom reporting
Number of subjects: 1015
Study 36435746 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 (recommendations summary)
Number of subjects: 239
Study 36435746 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 2 (recommendations summary and personalized feedback)
Number of subjects: 239
Study 36435746 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 239
Study 36435746 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (Intervention 1 and Intervention 2)
Number of subjects: 239
Study 36435746 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternatively funded providers
Number of subjects: 239
Study 36435746 — intervention group
Group type: EXPERIMENTAL
Intervention: Providers with a reduction in antibiotic prescribing
Number of subjects: 239
Study 33797734 — intervention group
Group type: EXPERIMENTAL
Intervention: End-to-end pancreatic anastomosis
Number of subjects: 74
Study 33797734 — intervention group
Group type: COMPARATOR
Intervention: Pancreaticojejunostomy
Number of subjects: 74
Study 33797734 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 74
Study 33140719 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot‐assisted training
Number of subjects: 770
Study 33140719 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy
Number of subjects: 770
Study 33140719 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 770
Study 35109577 — intervention group
Group type: EXPERIMENTAL
Intervention: NeuronUP-tDCS
Number of subjects: 53
Study 35109577 — intervention group
Group type: COMPARATOR
Intervention: NeuronUP-Sham
Number of subjects: 53
Study 35109577 — intervention group
Group type: EXPERIMENTAL
Intervention: Videogame-tDCS
Number of subjects: 53
Study 35109577 — intervention group
Group type: COMPARATOR
Intervention: Videogame-Sham
Number of subjects: 53
Study 35109577 — intervention group
Group type: COMPARATOR
Intervention: Active-control
Number of subjects: 53
Study 35109577 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Prospective Memory
Number of subjects: 53
Study 32224082 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) 1 g intravenously preoperatively
Number of subjects: 96
Study 32224082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 34499328 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) tool
Number of subjects: 350
Study 34499328 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 350
Study 34732509 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5560
Study 34732509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5560
Study 35130054 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g acetaminophen 4× daily
Number of subjects: 110
Study 35130054 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 110
Study 33812367 — intervention group
Group type: EXPERIMENTAL
Intervention: Likelihood Ratio Test (LRT)
Number of subjects: 0
Study 33812367 — intervention group
Group type: EXPERIMENTAL
Intervention: Wald tests with the between-within DF method
Number of subjects: 0
Study 33812367 — intervention group
Group type: EXPERIMENTAL
Intervention: Wald tests with the Satterthwaite DF approximation
Number of subjects: 0
Study 35806943 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-based format
Number of subjects: 500
Study 35806943 — intervention group
Group type: COMPARATOR
Intervention: Graphical format
Number of subjects: 500
Study 33200428 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide (LCM)
Number of subjects: 271
Study 33200428 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 271
Study 35912427 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramped position
Number of subjects: 82
Study 35912427 — intervention group
Group type: COMPARATOR
Intervention: Sniffing position
Number of subjects: 82
Study 34971331 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation of the rectus femoris and gastrocnemius muscles bilaterally, applied for 60 min, twice a day for up to 10 sessions until postoperative day 5.
Number of subjects: 88
Study 34971331 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (Control group)
Number of subjects: 88
Study 34971331 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Number of subjects: 88
Study 35801802 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram models for predicting lung metastasis (LM) incidence
Number of subjects: 10929
Study 35801802 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram models for evaluating overall survival (OS)
Number of subjects: 10929
Study 35801802 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram models for evaluating cancer-specific survival (CSS)
Number of subjects: 10929
Study 33763938 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ketamine
Number of subjects: 358
Study 33832142 — intervention group
Group type: EXPERIMENTAL
Intervention: FMS training 4 times per week for 12 weeks
Number of subjects: 71
Study 33879221 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupotomy
Number of subjects: 136
Study 33879221 — intervention group
Group type: COMPARATOR
Intervention: Sham acupotomy
Number of subjects: 136
Study 32096830 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen alternating with noninvasive ventilation
Number of subjects: 88
Study 32096830 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen alone
Number of subjects: 88
Study 35590297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavitary electrocardiogram (ECG) guidance
Number of subjects: 436
Study 35590297 — intervention group
Group type: COMPARATOR
Intervention: Chest computed tomography (CT)
Number of subjects: 436
Study 33351982 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azacitidine maintenance therapy
Number of subjects: 0
Study 32627354 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma ceramide levels (Cer(d18:1/16:0), Cer(d18:1/24:1))
Number of subjects: 200
Study 32627354 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma ratios of ceramides with Cer(d18:1/24:0)
Number of subjects: 200
Study 32627354 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted plasma ratios of ceramides with Cer(d18:1/24:0)
Number of subjects: 200
Study 34751784 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip-focused treatment
Number of subjects: 180
Study 34751784 — intervention group
Group type: COMPARATOR
Intervention: Spine-focused treatment
Number of subjects: 180
Study 35428621 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate biopsies post-MRI based on individualised risk estimation and shared decision-making
Number of subjects: 830
Study 35428621 — intervention group
Group type: COMPARATOR
Intervention: Prostate biopsies post-MRI for all men
Number of subjects: 830
Study 35182115 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment and prevention complex
Number of subjects: 90
Study 35182115 — intervention group
Group type: COMPARATOR
Intervention: Ultraphonophoresis with placebo
Number of subjects: 90
Study 33214094 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane-nitrous oxide
Number of subjects: 0
Study 33214094 — intervention group
Group type: COMPARATOR
Intervention: Desflurane alone
Number of subjects: 0
Study 33350370 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg single dose)
Number of subjects: 450
Study 33350370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 35698156 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app-based health care intervention for health management (6 weeks duration)
Number of subjects: 500
Study 35698156 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving health management information on paper
Number of subjects: 500
Study 34514614 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil plasma target concentration of 0 ng/ml (group R0)
Number of subjects: 75
Study 34514614 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil plasma target concentration of 1 ng/ml (group R1)
Number of subjects: 75
Study 34514614 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil plasma target concentration of 2 ng/ml (group R2)
Number of subjects: 75
Study 36194619 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Qurs‐e‐Asfar (QA) 778 mg twice a day and topical Rogan‐e‐Narjeel (RN)
Number of subjects: 78
Study 36194619 — intervention group
Group type: COMPARATOR
Intervention: Oral Itraconazole (100 mg/day) and topical Terbinafine hydrochloride (1%)
Number of subjects: 78
Study 36194619 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study 34710784 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil orally disintegrating strips
Number of subjects: 120
Study 34710784 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil tablets
Number of subjects: 120
Study 35848451 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral Block (PVB)
Number of subjects: 64
Study 35848451 — intervention group
Group type: COMPARATOR
Intervention: Mid-Point Transverse Process Pleura Block (MTP)
Number of subjects: 64
Study 33509742 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin gel
Number of subjects: 40
Study 33509742 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin mucoadhesive patches
Number of subjects: 40
Study 33509742 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study 36036079 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised 3D-printed osteotomy
Number of subjects: 22
Study 36036079 — intervention group
Group type: COMPARATOR
Intervention: Traditional osteotomy
Number of subjects: 22
Study 34535714 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance intervention (DI) for 6 months
Number of subjects: 99
Study 34535714 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance intervention (DI)
Number of subjects: 99
Study 34535714 — intervention group
Group type: COMPARATOR
Intervention: Cognitive reserve (CR)
Number of subjects: 99
Study 34789394 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m2 every 3 wk × 4 cycles)
Number of subjects: 195
Study 34789394 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 every 3 wk × 4 cycles)
Number of subjects: 195
Study 34789394 — intervention group
Group type: EXPERIMENTAL
Intervention: No specific intervention
Number of subjects: 195
Study 35098012 — intervention group
Group type: EXPERIMENTAL
Intervention: PERMA intervention
Number of subjects: 42
Study 35098012 — intervention group
Group type: EXPERIMENTAL
Intervention: IBCT intervention
Number of subjects: 42
Study 35098012 — intervention group
Group type: COMPARATOR
Intervention: Infertility treatment training program (Control)
Number of subjects: 42
Study 35098012 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 42
Study 35617841 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily hypertonic saline irrigation for 6 weeks
Number of subjects: 125
Study 35617841 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily saline/xylitol irrigation for 6 weeks
Number of subjects: 125
Study 32737844 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase II trials
Number of subjects: 0
Study 32737844 — intervention group
Group type: COMPARATOR
Intervention: Phase III trials
Number of subjects: 0
Study 32407786 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate cloths (Sage 2%) applied the night before and the morning of scheduled cesarean delivery.
Number of subjects: 1356
Study 32407786 — intervention group
Group type: COMPARATOR
Intervention: Placebo cloths (Sage Comfort Bath fragrance-free) applied the night before and the morning of scheduled cesarean delivery.
Number of subjects: 1356
Study 33446035 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based education
Number of subjects: 260
Study 33446035 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 260
Study 34516169 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (target BAC = .08%)
Number of subjects: 246
Study 34516169 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic control beverage
Number of subjects: 246
Study 32349693 — intervention group
Group type: EXPERIMENTAL
Intervention: SIP SMART intervention (two 45-min consultations including baseline clinical and instrumental swallowing assessment, educational information, targeted swallowing exercises, behaviour change strategies)
Number of subjects: 32
Study 32349693 — intervention group
Group type: EXPERIMENTAL
Intervention: SIP SMART intervention
Number of subjects: 32
Study 32349693 — intervention group
Group type: EXPERIMENTAL
Intervention: MD Anderson Dysphagia Inventory
Number of subjects: 32
Study 32349693 — intervention group
Group type: COMPARATOR
Intervention: Usual care (single session including baseline clinical assessment and generic information)
Number of subjects: 32
Study 36245363 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote patient monitoring (RPM)
Number of subjects: 0
Study 36245363 — intervention group
Group type: COMPARATOR
Intervention: In-clinic follow-up
Number of subjects: 0
Study 34918029 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 12
Study 34918029 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 12
Study 34918029 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study 33163057 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction program (group A)
Number of subjects: 80
Study 33163057 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 80
Study 36442225 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training at 30 Hz
Number of subjects: 93
Study 36442225 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training at 45 Hz
Number of subjects: 93
Study 36442225 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (general)
Number of subjects: 93
Study 36442225 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study 33705169 — intervention group
Group type: EXPERIMENTAL
Intervention: DESTRESS-WV (online, coach-assisted cognitive behavioral intervention)
Number of subjects: 102
Study 33705169 — intervention group
Group type: COMPARATOR
Intervention: Phone monitoring only (control)
Number of subjects: 102
Study 33705169 — intervention group
Group type: EXPERIMENTAL
Intervention: DESTRESS-WV
Number of subjects: 102
Study 33705169 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (DESTRESS-WV and phone monitoring)
Number of subjects: 102
Study 32134712 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning exercise at 60% V̇o2max for 1 hour
Number of subjects: 11
Study 32134712 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon exercise at 60% V̇o2max for 1 hour
Number of subjects: 11
Study 32134712 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 11
Study 34607768 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact Lenses (CL)
Number of subjects: 30
Study 34607768 — intervention group
Group type: COMPARATOR
Intervention: Spectacles (Sp)
Number of subjects: 30
Study 33368858 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744
Study 33368858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study 35132749 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalisation-based treatment (MBT)
Number of subjects: 32
Study 35132749 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical management (control)
Number of subjects: 32
Study 34127509 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT)
Number of subjects: 899
Study 34127509 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood DNA test
Number of subjects: 899
Study 34127509 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of either test (FIT or blood test)
Number of subjects: 899
Study 34127509 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal test within choice group
Number of subjects: 899
Study 34127509 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood test within choice group
Number of subjects: 899
Study 36268543 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based writing intervention (6 weeks, six structured writing assignments based on cognitive behavioral therapy)
Number of subjects: 86
Study 36268543 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based writing intervention
Number of subjects: 86
Study 32876107 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Mineral Density (BMD)
Number of subjects: 49
Study 32876107 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture Attributes (TAs)
Number of subjects: 49
Study 32876107 — intervention group
Group type: EXPERIMENTAL
Intervention: Interobserver Agreement
Number of subjects: 49
Study 34825283 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative prophylactic antibiotics
Number of subjects: 312
Study 34825283 — intervention group
Group type: COMPARATOR
Intervention: Control (no preoperative prophylactic antibiotics)
Number of subjects: 312
Study 35087846 — intervention group
Group type: EXPERIMENTAL
Intervention: Yijinjing Qigong Exercise (YJJQE)
Number of subjects: 50
Study 35087846 — intervention group
Group type: COMPARATOR
Intervention: Stretching training exercise (STE)
Number of subjects: 50
Study 36420685 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-enclosed electromechanical morcellation (LEM)
Number of subjects: 118
Study 36420685 — intervention group
Group type: COMPARATOR
Intervention: Vaginal-enclosed scalpel morcellation (VSM)
Number of subjects: 118
Study 32862425 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise (12 weeks, twice weekly)
Number of subjects: 0
Study 32862425 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise (per protocol analysis, ≥75% attendance)
Number of subjects: 0
Study 32862425 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise (8 weeks postpartum)
Number of subjects: 0
Study 32862425 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 36808268 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimegepant 75 mg ODT
Number of subjects: 16
Study 36808268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34618162 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 421
Study 34618162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study 36891452 — intervention group
Group type: EXPERIMENTAL
Intervention: PECs II block with 25 ml of 0.25% bupivacaine
Number of subjects: 60
Study 36891452 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PECs II block)
Number of subjects: 60
Study 36891452 — intervention group
Group type: EXPERIMENTAL
Intervention: PECs II block
Number of subjects: 60
Study 34288696 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months of FOLFIRINOX (arm A)
Number of subjects: 276
Study 34288696 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 months of FOLFIRINOX followed by leucovorin plus fluorouracil maintenance treatment (arm B)
Number of subjects: 276
Study 34288696 — intervention group
Group type: COMPARATOR
Intervention: Sequential treatment alternating gemcitabine and fluorouracil, leucovorin, and irinotecan every 2 months (arm C)
Number of subjects: 276
Study 32441655 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning involving traditional lectures plus m-learning via the iPOT app
Number of subjects: 99
Study 32441655 — intervention group
Group type: COMPARATOR
Intervention: Traditional on-site learning
Number of subjects: 99
Study 32441655 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent users of the iPOT app
Number of subjects: 99
Study 35076797 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP taken by daily pill
Number of subjects: 694
Study 35076797 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP by injection
Number of subjects: 694
Study 35076797 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP by pill
Number of subjects: 694
Study 35076797 — intervention group
Group type: EXPERIMENTAL
Intervention: Other PrEP modalities (event-based pill, anal suppository, gel, condoms)
Number of subjects: 694
Study 32246765 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (intrauterine infusion)
Number of subjects: 304
Study 32246765 — intervention group
Group type: COMPARATOR
Intervention: Control (gel without GM-CSF)
Number of subjects: 304
Study 35618335 — intervention group
Group type: EXPERIMENTAL
Intervention: AWARE intervention (360° multimodal intervention)
Number of subjects: 120
Study 35618335 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 120
Study 35618335 — intervention group
Group type: EXPERIMENTAL
Intervention: AWARE intervention
Number of subjects: 120